SCHEMBL2677397

SCHEMBL2677397

COCC1(C)NC(=O)C(c2cc(-c3ccc(Cl)cc3)ccc2C)C1=O

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACACB O00763 7/20 0.41
ACACA Q13085 7/20 0.41
PGR P06401 3/20 0.35
RECQL P46063 1/20 0.31
ABCC1 P33527 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676263 0.90 ACACB (0.36) ACACBACACAPGRRECQL
SCHEMBL2678574 0.85 ACACB (0.38) ACACBACACAPGRRECQLABCC1
SCHEMBL11025445 0.82 ACACB (0.38) ACACBACACAPGRRECQL
SCHEMBL2678581 0.80 ACACB (0.36) ACACBACACA
SCHEMBL2759720 0.74 ACACB (0.42) ACACBACACAPGR
SCHEMBL1550368 0.71 PGR (0.42) ACACBACACAPGR
SCHEMBL4546196 0.70 ACACB (0.67) ACACBACACAPGRRECQL
SCHEMBL2676330 0.70 ACACB (0.33) ACACBACACARECQL
SCHEMBL2677177 0.69
SCHEMBL8558103 0.69 MDM2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173697-B2 Alkoxyalkyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG (DE) 2012-05-08 US disclosed
US-20090298828-A1 Alkoxyalkyl-Substituted Cyclic Keto-Enols BAYER CROPSCIENCE AG (DE) 2009-12-03 US disclosed
EP-2029531-A1 ALKOXYALKYL-SUBSTITUTED CYCLIC KETO-ENOLS Bayer CropScience AG (DE) 2009-03-04 EP disclosed
WO-2007140881-A1 ALKOXYALKYL-SUBSTITUTED CYCLIC KETO-ENOLS BAYER CROPSCIENCE AG (DE) 2007-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298828-A1 Alkoxyalkyl-Substituted Cyclic Keto-Enols DDT, AKR1D1, EBP ACACB 249/4885ACACA 529/4885PGR 2132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.